Clinical trial
Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen…
NCT00301457 · Maastricht University Medical Center, Other · Completed
Key facts
| NCT number | NCT00301457 |
|---|---|
| Title | Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer |
| Official title | A Prospective Randomised, Open, Multicentre, Phase III Study to Assess Different Durations of Anastrozole Therapy After 2 to 3 Years Tamoxifen as Adjuvant Therapy in Postmenopausal Women With Breast Cancer. |
| Acronym | DATA |
| Lead sponsor | Maastricht University Medical Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Anastrozole |
| Enrollment | 1,914 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2022 |
| Completion | Apr 1, 2022 |
| First posted | Mar 13, 2006 |
| Last update posted | Feb 21, 2023 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: